Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120883482 | 12088348 | 2 | F | 20160818 | 20160218 | 20160824 | EXP | CA-AMGEN-CANSP2016018659 | AMGEN | 44.00 | YR | A | M | Y | 0.00000 | 20160824 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120883482 | 12088348 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, 1 EVERY 1 WEEK | U | 103795 | 50 | MG | UNKNOWN FORMULATION | /wk | |||||
| 120883482 | 12088348 | 2 | SS | CELEBREX | CELECOXIB | 1 | Oral | UNK | 0 | CAPSULE | |||||||||
| 120883482 | 12088348 | 3 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 20 MG, 1 EVERY 1 WEEK | 0 | 20 | MG | /wk | |||||||
| 120883482 | 12088348 | 4 | SS | ORENCIA | ABATACEPT | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 120883482 | 12088348 | 5 | SS | ORENCIA | ABATACEPT | 1 | Subcutaneous | UNK | 0 | ||||||||||
| 120883482 | 12088348 | 6 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | 400 MG, QD | 0 | 400 | MG | TABLET | QD | ||||||
| 120883482 | 12088348 | 7 | SS | REMICADE | INFLIXIMAB | 1 | Unknown | 3 MG/KG, CYCLICAL | 0 | 3 | MG/KG | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | |||||||
| 120883482 | 12088348 | 8 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 1 G, BID | 0 | 1 | G | BID | |||||||
| 120883482 | 12088348 | 9 | C | PREDNISONE. | PREDNISONE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120883482 | 12088348 | 1 | Product used for unknown indication |
| 120883482 | 12088348 | 2 | Rheumatoid arthritis |
| 120883482 | 12088348 | 3 | Rheumatoid arthritis |
| 120883482 | 12088348 | 4 | Product used for unknown indication |
| 120883482 | 12088348 | 6 | Product used for unknown indication |
| 120883482 | 12088348 | 7 | Product used for unknown indication |
| 120883482 | 12088348 | 8 | Product used for unknown indication |
| 120883482 | 12088348 | 9 | Arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120883482 | 12088348 | HO |
| 120883482 | 12088348 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120883482 | 12088348 | Abdominal discomfort | |
| 120883482 | 12088348 | Condition aggravated | |
| 120883482 | 12088348 | Disease progression | |
| 120883482 | 12088348 | Drug ineffective | |
| 120883482 | 12088348 | Drug intolerance | |
| 120883482 | 12088348 | Impaired work ability | |
| 120883482 | 12088348 | Internal haemorrhage | |
| 120883482 | 12088348 | Respiratory arrest | |
| 120883482 | 12088348 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |